• Avacta Therapeutics appoints Patrick Vink as deputy chair Sharecast.com Wed, 08 Jul 2026 11:20:33 GMT
• avacta appoints healthcare executive patrick vink as deputy chairman of the board of directors Yahoo! Finance Canada Wed, 08 Jul 2026 06:00:00 GMT
• Spero Therapeutics outlines its antibiotic pipeline as investors track regulatory progress AD HOC NEWS Tue, 07 Jul 2026 17:13:55 GMT
• spero shares jump after fda clears first oral carbapenem antibiotic for us market (spro) MSN Tue, 30 Jun 2026 10:54:05 GMT
• Spero Therapeutics, Inc.(NasdaqGS: SPRO) added to Russell Microcap Index marketscreener.com Mon, 29 Jun 2026 05:31:22 GMT
• Spero Therapeutics, Inc.(NasdaqGS:SPRO) added to Russell Microcap Growth Benchmark Index marketscreener.com Sun, 28 Jun 2026 07:00:00 GMT
• spero therapeutics, inc. actuals & estimates (nasdaq:spro) TradingView Fri, 26 Jun 2026 09:23:23 GMT
• spero therapeutics expands stock incentive plan and authorization The Globe and Mail Fri, 26 Jun 2026 07:00:00 GMT
• Form 4 Spero Therapeutics Inc For: 25 June By Investing.com Investing.com Nigeria Fri, 26 Jun 2026 02:24:08 GMT
• Form 4 Spero Therapeutics Inc For: 25 June By Investing.com Investing.com UK Thu, 25 Jun 2026 23:02:00 GMT
• Spero Therapeutics (SPRO) grants director RSUs and 20,000 stock options Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
• Spero Therapeutics (SPRO) director awarded RSUs and stock options Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
• Spero Therapeutics (SPRO) director receives RSU and stock option awards Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
• Spero Therapeutics (SPRO) director receives 10,000 RSUs and 20,000-share option grant Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
• Spero Therapeutics (NASDAQ: SPRO) doubles share authorization and adopts 2026 stock plan Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
• Equity awards to Spero (NASDAQ: SPRO) director Scott Jackson Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
• Spero Therapeutics (SPRO) Slips 3.81% as Selling Pressure Tests Key Support Levels - Systematic Flow dars.gov.et Thu, 25 Jun 2026 07:00:00 GMT
• spero therapeutics (spro) short interest & short float | updated jun 2026 MarketBeat Thu, 25 Jun 2026 07:00:00 GMT
• spero therapeutics inc (spro) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• fda clears spero (nasdaq: spro) oral utebzi antibiotic for complicated utis Stock Titan Mon, 22 Jun 2026 20:05:06 GMT
• Spero Therapeutics Inc (NASDAQ: SPRO) Share Price, SPRO Stock News, SPRO Share Price & Updates Kalkine Sat, 20 Jun 2026 11:43:53 GMT
• us fda approves gsk's oral antibiotic for drug-resistant utis Reuters Fri, 19 Jun 2026 09:13:42 GMT
• spero therapeutics inc (nasdaq: spro) share price, spro stock news, spro share price & updates Kalkine Fri, 19 Jun 2026 00:00:00 GMT
• Spero Therapeutics Stock: Antibiotic Development In Focus Kalkine Media Thu, 18 Jun 2026 18:56:00 GMT
• spero shares jump after fda clears first oral carbapenem antibiotic for us market (spro) MSN Thu, 18 Jun 2026 17:36:02 GMT
• gsk, spero win approval of utebzi for complicated urinary tract infections MSN Thu, 18 Jun 2026 15:47:45 GMT
• fda approves utebzi, first oral carbapenem antibiotic, for complicated utis Manufacturing Chemist Thu, 18 Jun 2026 10:10:43 GMT
• Spero Therapeutics stock surges on FDA approval of Utebzi Investing.com Thu, 18 Jun 2026 07:00:00 GMT
• Spero Therapeutics: Yesterday's Selloff On Utebzi Approval Seems Bewildering (NASDAQ:SPRO) Seeking Alpha Thu, 18 Jun 2026 07:00:00 GMT
• US FDA approves GSK's oral antibiotic for drug-resistant UTIs Reuters Thu, 18 Jun 2026 07:00:00 GMT
• GSK, Spero’s oral antibiotic wins first FDA nod for complicated UTI BioSpace Thu, 18 Jun 2026 07:00:00 GMT
• spero therapeutics inc (spro) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• spero therapeutics inc (spro) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• spero therapeutics inc (spro) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• utebzi (tebipenem pivoxil) approved in the us for adults with complicated urinary tract infections (cutis) GSK Thu, 18 Jun 2026 00:59:24 GMT
• gsk and spero's oral carbapenem is first to win fda approval for cutis FirstWord Pharma Thu, 18 Jun 2026 00:23:04 GMT
• spero therapeutics inc (spro) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 22:48:39 GMT
• spero therapeutics inc (spro) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 22:47:07 GMT
• us fda approves gsk's oral antibiotic for drug-resistant utis Reuters Wed, 17 Jun 2026 22:09:07 GMT
• Spero Therapeutics Inc (SPRO) Dividends & Stock Splits: Historical Payouts and Event Timeline TradingKey Wed, 17 Jun 2026 21:52:53 GMT
• spero therapeutics inc (spro) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 10:48:29 GMT
• spero therapeutics inc (spro) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 08:23:50 GMT
• spero therapeutics inc (spro) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 07:57:09 GMT
• spero therapeutics inc (spro) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 07:52:21 GMT
• spero therapeutics inc (spro) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 07:49:52 GMT
• 4 years after snub, GSK partnership helps Spero get Utebzi across FDA finish line Fierce Pharma Wed, 17 Jun 2026 07:00:00 GMT
• Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs) GSK Wed, 17 Jun 2026 07:00:00 GMT
• FDA approves tebipenem pivoxil as first oral carbapenem antibiotic for complicated urinary tract infections Contemporary OB/GYN Wed, 17 Jun 2026 07:00:00 GMT
• Spero Therapeutics Approaches Key FDA Decision For Tebipenem HBr In CUTIs RTTNews Wed, 17 Jun 2026 07:00:00 GMT
• Spero Therapeutics and GSK Announce FDA Approval of Utebzi, the First Oral Carbapenem Antibiotic for Complicated Urinary Tract Inf... Quiver Quantitative Wed, 17 Jun 2026 07:00:00 GMT
• SPRO Stock Slumps As Volatility Grips Small-Cap Biotech timothysykes.com Wed, 17 Jun 2026 07:00:00 GMT
• GSK, Spero Therapeutics Gain U.S. Approval for Utebzi marketscreener.com Wed, 17 Jun 2026 07:00:00 GMT
• FDA approves first oral carbapenem for complicated UTIs in adults Stock Titan Wed, 17 Jun 2026 07:00:00 GMT
• GSK, Spero Therapeutics Get FDA Approval for Utebzi in Complicated Urinary Tract Infections Moomoo Wed, 17 Jun 2026 07:00:00 GMT
• FDA approves first oral carbapenem therapy for cUTIs The Pharma Letter Wed, 17 Jun 2026 07:00:00 GMT
• GSK, Spero Win FDA Nod For First-Ever Oral Carbapenem Antibiotic For Complicated UTIs Benzinga Wed, 17 Jun 2026 07:00:00 GMT
• AlTi Global And 2 Other Promising Penny Stocks To Watch simplywall.st Wed, 17 Jun 2026 07:00:00 GMT
• spero therapeutics stock (us85208t1079): quiet session keeps focus on fundamentals and pipeline AD HOC NEWS Tue, 16 Jun 2026 12:03:10 GMT
• spro q1 2026 earnings: narrower-than-expected loss boosts sentiment - slow growth warning dars.gov.et Sat, 13 Jun 2026 07:00:00 GMT
• Spero Therapeutics Q1 2026 Earnings: EPS Beat Despite Revenue Lull, Stock Edges Higher - Performance Review dars.gov.et Fri, 12 Jun 2026 07:00:00 GMT
• Spero Therapeutics: Approval Upside, Commercial Friction (Initiating Hold) Seeking Alpha Mon, 08 Jun 2026 07:00:00 GMT
• Spero Therapeutics Inc. Q1 2026 Earnings: Better-Than-Expected Loss Provides Little Respite as Shares Fall - Margin Guidance dars.gov.et Sun, 07 Jun 2026 07:00:00 GMT
• spero therapeutics q1 2026 earnings: narrower loss beats estimates, but stock falls amid lack of revenue newsline.com Fri, 05 Jun 2026 07:00:00 GMT
• spero therapeutics stock (us85208t1079): stable nasdaq pricing after may earnings update AD HOC NEWS Thu, 04 Jun 2026 07:00:00 GMT
• spro q1 2026 earnings: narrowed loss surpasses estimates, stock flat amid no revenue - profit growth outlook newsline.com Mon, 01 Jun 2026 07:00:00 GMT
• spero therapeutics (spro) slips 2.41% as stock tests key support at $2.69 - dark pool volume newsline.com Fri, 29 May 2026 07:00:00 GMT
• spero therapeutics (spro) hovers near support amid modest decline – key levels in focus - sentiment shift newsline.com Thu, 28 May 2026 07:00:00 GMT
• spero therapeutics (spro) jumps 4.9% as stock approaches key resistance at $3.15 - oversold bounce ideas The Legal Advocate Wed, 27 May 2026 18:32:02 GMT
• spro technical analysis | trend, signals & chart patterns | spero therapeutics inc (nasdaq:spro) ChartMill Fri, 22 May 2026 07:00:00 GMT
• spero therapeutics (spro) q1 2026 earnings: why the beat matters - earnings miss alert The Legal Advocate Thu, 21 May 2026 07:00:00 GMT
• spero therapeutics (spro) delivers q1 2026 beat — eps $-0.13 vs $-0.18 expected - earnings miss alert newsline.com Tue, 19 May 2026 07:00:00 GMT
• spero therapeutics, inc. common stock (spro) stock price today & analysis Gotrade Sun, 17 May 2026 08:31:05 GMT
• spero therapeutics, inc. common stock spro ) stock price today & analysis Gotrade Sun, 17 May 2026 08:31:05 GMT
• spero therapeutics reports q1 2026 loss narrows; fda to decide on oral antibiotic tebipenem hbr in june Pluang Thu, 14 May 2026 10:38:50 GMT
• spero therapeutics stock (us85208t1079): q1 2026 results and fda catalyst in focus AD HOC NEWS Thu, 14 May 2026 07:00:00 GMT
• is spero therapeutics (spro) 110.3% overvalued after q1 2026 ear GuruFocus Thu, 14 May 2026 02:14:53 GMT
• Spero Therapeutics Announces First Quarter 2026 Operating Results and Provides Business Update GlobeNewswire Wed, 13 May 2026 07:00:00 GMT
• Spero Therapeutics (SPRO) trims Q1 2026 loss ahead key tebipenem FDA date Stock Titan Wed, 13 May 2026 07:00:00 GMT
• Spero Therapeutics Q1 revenue drops on decreased clinical activity TradingView Wed, 13 May 2026 07:00:00 GMT
• is spero therapeutics (spro) 110.3% overvalued after q1 2026 ear GuruFocus Wed, 13 May 2026 07:00:00 GMT
• spero therapeutics reports q1 2026 loss narrows; fda to decide on oral antibiotic tebipenem hbr in june Pluang Wed, 13 May 2026 07:00:00 GMT
• fda to rule june 18 on spero oral antibiotic for severe utis Stock Titan Wed, 13 May 2026 07:00:00 GMT
• spero therapeutics (nasdaq: spro) leans on gsk-partnered tebipenem ahead june 2026 fda date Stock Titan Wed, 13 May 2026 07:00:00 GMT
• spero therapeutics, inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Wed, 13 May 2026 07:00:00 GMT
• number of shareholders of spero therapeutics, inc. – nasdaq:spro TradingView Sat, 09 May 2026 15:51:08 GMT
• spro sec filings - spero therapeuti 10-k, 10-q, 8-k forms Stock Titan Fri, 08 May 2026 19:20:01 GMT
• spero therapeutics (spro.us) will release its earnings report after the market closes on may 13. 富途牛牛 Fri, 08 May 2026 04:33:01 GMT
• spro final deadline today: rosen, a globally recognized firm, encourages spero therapeutics, inc. investors with losses to secure ... TMX Newsfile Thu, 07 May 2026 08:01:14 GMT
• spero therapeutics (spro.us) will release its earnings report after the market closes on may 13. 富途牛牛 Thu, 07 May 2026 07:00:00 GMT
• spero therapeutics (spro) officer sells shares for rsu tax obligations Stock Titan Thu, 07 May 2026 02:22:19 GMT
• spero therapeutics to report first quarter 2026 financial results and provide business update on may 13, 2026 The Manila Times Wed, 06 May 2026 07:00:00 GMT
• spero therapeutics (spro) officer sells shares for rsu tax obligations Stock Titan Wed, 06 May 2026 07:00:00 GMT
• insider selling: spero therapeutics (nasdaq:spro) insider sells 25,240 shares of stock MarketBeat Wed, 06 May 2026 07:00:00 GMT
• spero therapeutics (spro) to release quarterly earnings on wednesday MarketBeat Wed, 06 May 2026 07:00:00 GMT
• no call planned as spero sets may 13 for q1 results update Stock Titan Tue, 05 May 2026 20:30:59 GMT
• Spero Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 13, 2026 GlobeNewswire Tue, 05 May 2026 07:00:00 GMT
• spero therapeutics to report q1 2026 financial results and business update on may 13 Pluang Tue, 05 May 2026 07:00:00 GMT
• spro stock price, quote & chart | spero therapeutics inc (nasdaq:spro) ChartMill Fri, 01 May 2026 07:00:00 GMT
• spero therapeutics, inc. (nasdaq:spro) sees significant growth in short interest MarketBeat Thu, 30 Apr 2026 07:00:00 GMT
• spero therapeutics (spro) price target decreased by 20.00% to 4.08 MSN Mon, 27 Apr 2026 17:33:51 GMT
• Spero Therapeutics (NASDAQ: SPRO) 2026 proxy adds stock increase and new incentive plan Stock Titan Mon, 27 Apr 2026 07:00:00 GMT
• spro forecast, price target & analyst ratings | spero therapeutics inc (nasdaq:spro) ChartMill Mon, 27 Apr 2026 07:00:00 GMT
• rosen, top ranked investor counsel, encourages spero therapeutics, inc. investors with losses to secure counsel before important d... TMX Newsfile Sat, 25 Apr 2026 04:04:16 GMT
• spero therapeutics (spro) stock volume spike alert (builds on momentum) 2026-04-20 - open stock picks Cổng thông tin điện tử tỉnh Lào Cai Tue, 21 Apr 2026 03:46:12 GMT
• spero therapeutics (spro) stock volume spike alert (builds on momentum) 2026-04-20 - double ema Newser Mon, 20 Apr 2026 07:00:00 GMT
• spero therapeutics (spro) stock insider buying (market focus) 2026-04-18 - fund manager survey newsline.com Sat, 18 Apr 2026 07:00:00 GMT
• spro forecast, price target & analyst ratings | spero therapeutics inc (nasdaq:spro) ChartMill Fri, 17 Apr 2026 07:00:00 GMT
• spero therapeutics (nasdaq:spro) share price passes above 50 day moving average - what's next? MarketBeat Thu, 16 Apr 2026 07:00:00 GMT
• spero therapeutics (nasdaq: spro) asks shareholders to double authorized shares to 240m Stock Titan Mon, 13 Apr 2026 07:00:00 GMT
• portfolio shifts: is spero therapeutics inc stock showing strong momentum - 2026 rallies & ai forecasted entry/exit points baoquankhu1.vn Sat, 11 Apr 2026 15:33:25 GMT
• macd signal: does spero therapeutics inc have pricing power - 2026 growth vs value & verified swing trading watchlist baoquankhu1.vn Fri, 10 Apr 2026 13:48:13 GMT
• can spero therapeutics (spro) stock increase dividends | price at $2.63, down 5.40% - getlinesfromresbyarray error: size == 0 lwvtexas.org Fri, 10 Apr 2026 07:00:00 GMT
• is spero therapeutics (spro) stock undervalued by the market | price at $2.73, up 0.55% - put wall newsline.com Thu, 09 Apr 2026 07:00:00 GMT
• non tuberculous mycobacterial infections market: high-growth opportunities for investors to 2034 – delveinsight | insmed, an2 ther... Barchart Thu, 09 Apr 2026 07:00:00 GMT
• spero therapeutics (spro) price target decreased by 20.00% to 4.08 MSN Wed, 08 Apr 2026 20:36:42 GMT
• gains recap: is greenlight capital re ltd exposed to currency risks - 2026 stock rankings & accurate entry and exit point alerts baoquankhu1.vn Wed, 08 Apr 2026 13:51:24 GMT
• market overview: will spero therapeutics inc benefit from seasonality - 2026 pullbacks & capital efficiency focused ideas baoquankhu1.vn Wed, 08 Apr 2026 13:51:24 GMT
• market review: what is the peg ratio of spero therapeutics inc - inflation watch & safe capital growth stock tips baoquankhu1.vn Wed, 08 Apr 2026 11:39:01 GMT
• is spero therapeutics (spro) stock reacting to market | price at $2.73, up 2.43% - golden cross newsline.com Wed, 08 Apr 2026 07:00:00 GMT
• spero therapeutics: a pivotal fda decision approaches () aktiencheck.de Wed, 08 Apr 2026 07:00:00 GMT
• spero therapeutics (nasdaq:spro) stock price passes above 50-day moving average - time to sell? MarketBeat Tue, 07 Apr 2026 07:00:00 GMT
• is spero therapeutics (spro) stock growing now | price at $2.54, up 4.32% - iv percentile The Legal Advocate Mon, 06 Apr 2026 07:00:00 GMT
• spro forecast, price target & analyst ratings | spero therapeutics inc (nasdaq:spro) ChartMill Mon, 06 Apr 2026 07:00:00 GMT
• spero therapeutics secures financial stability through 2028 () aktiencheck.de Fri, 03 Apr 2026 23:49:00 GMT
Spero Therapeutics, Inc(NASDAQ:SPRO) 
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. Its product candidates include tebipenem pivoxil hydrobromide (HB...
Website: http://sperotherapeutics.com
Founded: 2013
Full Time Employees: 57
Sector: Healthcare
Industry: Biotechnology